FDA NDC Directory · JSON-LD · Markdown

Dextroamphetamine Saccharate, Amphetamine Aspartate, Dextroamphetamine Sulfate and Amphetamine Sulfate

NDC 72516-012 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerOryza Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA210293
Dosage form / routeTABLET · ORAL
Active ingredientsAMPHETAMINE ASPARTATE MONOHYDRATE (5 mg/1)
AMPHETAMINE SULFATE (5 mg/1)
DEXTROAMPHETAMINE SACCHARATE (5 mg/1)
DEXTROAMPHETAMINE SULFATE (5 mg/1)
Marketing started20201019
Package count1

External sources

Source: openFDA. Public-domain (CC0).